Literature DB >> 18558871

Prioritization of influenza pandemic vaccination to minimize years of life lost.

Mark A Miller1, Cecile Viboud, Donald R Olson, Rebecca F Grais, Maia A Rabaa, Lone Simonsen.   

Abstract

BACKGROUND: How to allocate limited vaccine supplies in the event of an influenza pandemic is currently under debate. Conventional vaccination strategies focus on those at highest risk for severe outcomes, including seniors, but do not consider (1) the signature pandemic pattern in which mortality risk is shifted to younger ages, (2) likely reduced vaccine response in seniors, and (3) differences in remaining years of life with age.
METHODS: We integrated these factors to project the age-specific years of life lost (YLL) and saved in a future pandemic, on the basis of mortality patterns from 3 historical pandemics, age-specific vaccine efficacy, and the 2000 US population structure.
RESULTS: For a 1918-like scenario, the absolute mortality risk is highest in people <45 years old; in contrast, seniors (those >or=65 years old) have the highest mortality risk in the 1957 and 1968 scenarios. The greatest YLL savings would be achieved by targeting different age groups in each scenario; people <45 years old in the 1918 scenario, people 45-64 years old in the 1968 scenario, and people >45 years old in the 1957 scenario.
CONCLUSIONS: Our findings shift the focus of pandemic vaccination strategies onto younger populations and illustrate the need for real-time surveillance of mortality patterns in a future pandemic. Flexible setting of vaccination priority is essential to minimize mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558871      PMCID: PMC3206321          DOI: 10.1086/589716

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

Review 1.  Antibody response to influenza vaccination in the elderly: a quantitative review.

Authors:  Katherine Goodwin; Cécile Viboud; Lone Simonsen
Journal:  Vaccine       Date:  2005-09-19       Impact factor: 3.641

2.  A socially neutral disease? Individual social class, household wealth and mortality from Spanish influenza in two socially contrasting parishes in Kristiania 1918-19.

Authors:  Svenn-Erik Mamelund
Journal:  Soc Sci Med       Date:  2005-08-08       Impact factor: 4.634

3.  The ethics of influenza vaccination.

Authors:  Robin P Silverstein
Journal:  Science       Date:  2006-08-11       Impact factor: 47.728

4.  The ethics of influenza vaccination.

Authors:  Harvey S Frey
Journal:  Science       Date:  2006-08-11       Impact factor: 47.728

5.  The ethics of influenza vaccination.

Authors:  Alison P Galvani; Jan Medlock; Gretchen B Chapman
Journal:  Science       Date:  2006-08-11       Impact factor: 47.728

6.  Medical countermeasures for pandemic influenza: ethics and the law.

Authors:  Lawrence O Gostin
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

7.  Public health. Who should get influenza vaccine when not all can?

Authors:  Ezekiel J Emanuel; Alan Wertheimer
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

8.  What can we learn from reconstructing the extinct 1918 pandemic influenza virus?

Authors:  Peter Palese; Terrence M Tumpey; Adolfo Garcia-Sastre
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

9.  Mitigation strategies for pandemic influenza in the United States.

Authors:  Timothy C Germann; Kai Kadau; Ira M Longini; Catherine A Macken
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

10.  Strategies for mitigating an influenza pandemic.

Authors:  Neil M Ferguson; Derek A T Cummings; Christophe Fraser; James C Cajka; Philip C Cooley; Donald S Burke
Journal:  Nature       Date:  2006-04-26       Impact factor: 49.962

View more
  32 in total

1.  Changing perceptions: of pandemic influenza and public health responses.

Authors:  Adam Kamradt-Scott
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift.

Authors:  Neslihan Saglanmak; Viggo Andreasen; Lone Simonsen; Kåre Mølbak; Mark A Miller; Cécile Viboud
Journal:  Vaccine       Date:  2011-07-22       Impact factor: 3.641

3.  Years of life lost in the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong.

Authors:  Ying Zhou; Eric H Y Lau; Dennis K M Ip; Hiroshi Nishiura; Gabriel M Leung; Wing-Hong Seto; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2013-08-26       Impact factor: 4.897

4.  Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.

Authors:  Marc Lipsitch; Lyn Finelli; Richard T Heffernan; Gabriel M Leung; Stephen C Redd
Journal:  Biosecur Bioterror       Date:  2011-06

5.  The Influence of Hispanic Ethnicity and Nativity Status on 2009 H1N1 Pandemic Vaccination Uptake in the United States.

Authors:  Andrew E Burger; Eric N Reither; Erin Trouth Hofmann; Svenn-Erik Mamelund
Journal:  J Immigr Minor Health       Date:  2018-06

6.  Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza.

Authors:  Ashleigh R Tuite; Amy L Greer; Michael Whelan; Anne-Luise Winter; Brenda Lee; Ping Yan; Jianhong Wu; Seyed Moghadas; David Buckeridge; Babak Pourbohloul; David N Fisman
Journal:  CMAJ       Date:  2009-12-03       Impact factor: 8.262

7.  Optimal pandemic influenza vaccine allocation strategies for the Canadian population.

Authors:  Ashleigh R Tuite; David N Fisman; Jeffrey C Kwong; Amy L Greer
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

8.  Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons.

Authors:  Cecile Viboud; Mark Miller; Don Olson; Michael Osterholm; Lone Simonsen
Journal:  PLoS Curr       Date:  2010-03-20

9.  The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis.

Authors:  Anne M Presanis; Daniela De Angelis; Angela Hagy; Carrie Reed; Steven Riley; Ben S Cooper; Lyn Finelli; Paul Biedrzycki; Marc Lipsitch
Journal:  PLoS Med       Date:  2009-12-08       Impact factor: 11.069

10.  Optimal pandemic influenza vaccine allocation strategies for the canadian population.

Authors:  Ashleigh Tuite; David N Fisman; Jeffrey C Kwong; Amy Greer
Journal:  PLoS Curr       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.